218 THE PROTEOMORPHIC THEORY AND THE NEW MEDICINE 



It will be recalled that I listed lymphatic and myologenous leukae- 

 mias and pernicious anaemia, and such seemingly diverse con- 

 ditions as anaemic obesity, Graves' disease, arthritis, arterio- 

 sclerosis, and neoplasms of all types under a common heading 

 as evidence of the "cancerous condition." The detailed expo- 

 sition of a certain number of typical cases in recent pages has 

 been intended to illustrate in some measure the validity of this 

 classification. In my original exposition of the principles of 

 protein therapy, so often referred to in these pages, I spoke of 

 the proteantigen response as applicable to all types of protein 

 infection. The present entire volume is but an elaboration of 

 that thesis. 



It is perhaps unnecessary to detail further individual cases 

 to emphasize the opinion that disturbances of the blood grow- 

 ing out of abnormal alimentation may be aetiologically connected 

 with many types of maladies that have not hitherto been asso- 

 ciated in the mind of the average practitioner. It should be 

 axiomatic to say, however, that abnormal modifications of the 

 blood must have wide and various implications in disturbed 

 functionings of the bodily organs. It is scarcely too much to 

 say that there are no maladies that are not to some extent asso- 

 ciated with disturbances of metabolism that must register them- 

 selves in the blood, whether or not we are able to read the record. 



Every practical physician knows how prevalent are anaemias 

 of various types, whether or not associated with recognized 

 sources of protein infection. But the manner of association 

 the universality of disturbed protein metabolism as a factor in 

 producing anaemias was perhaps never so adequately explicable 

 on any other hypothesis as it becomes when interpreted in the 

 light of the Proteomorphic theory. And assuredly there is no 

 remedial agent hitherto available that so directly and so explic- 

 itly goes to the source of disturbance and tends to correct it as 

 do the proteantigens. 



It will be a little difficult for the profession to accustom 

 itself to the idea that the same line of treatment, modified to 

 meet individual cases, may be applicable to maladies recorded 

 under such diverse headings as intestinal toxaemias, anaemias, 

 arthritis, psoriasis, asthma, tuberculosis, and cancer. But when 

 the idea is clearly grasped that there are important underlying 

 causal factors that are the same for all these conditions, the 

 logicality of the protein treatment will be obvious. 



And I predict with much confidence that the practical physi- 

 cian, whatever his attitude toward theories of therapeutic action, 

 will feel that Proteal medication places in his hands a new 

 weapon of unique value in the treatment of a wide range of 

 maladies of middle life and old age that hitherto have proved 



